Please note Supercomnet's factory operations are running as normal.
STB production activities remain undisrupted despite the Covid-19 pandemic, and affirmed its ability to meet the sudden increase in product orders.
STB has received the approval from the Ministry of International Trade and Industry (MITI) to allow the group's subsidiaries, Supercomal Medical Products Sdn Bhd (SMP) and Supercomal Technologies Sdn Bhd (SCTB) to operate during the Movement Control Order (MCO) from March 18 to April 14.
The plants are operating at maximum level for critical devices used for Covid-19 treatment. We are confident of fulfilling our existing customer orders for the year. I would also like to thank the government's support and our hardworking staff for all their efforts during this time," said the company spokesperson.
For its financial year (FY) ended Dec 31, 2019, STB recorded a 54.61 per cent jump in net profit to RM18.82 million on the back of a 39.28 per cent increase in revenue to RM122.97 million.
The Group currently has a dividend yield of 3 per cent based on the 1.5 sen it distributed last year.
0001 SCOMNET SUPERCOMNET TECHNOLOGIES BHD Quarterly rpt on consolidated results for the financial period ended 31/12/2019 Quarter: 4th Quarter Financial Year End: 31/12/2019 Report Status: Unaudited Submitted By: Current Year Quarter Preceding Year Corresponding Quarter Current Year to Date Preceding Year Corresponding Period 31/12/2019 31/12/2018 31/12/2019 31/12/2018 RM '000 RM '000 RM '000 RM '000 1 Revenue 32,396 27,206 122,969 88,288 2 Profit/Loss Before Tax 4,919 3,127 23,613 16,092 3 Profit/(loss) attributable to ordinary equity holders of the parent 4,560 2,020 18,821 12,173 4 Net Profit/Loss For The Period 4,560 2,020 18,821 12,173 5 Basic Earnings/Loss Per Shares (sen) 0.71 0.31 2.93 1.89 6 Dividend Per Share (sen) 0.00 0.00 1.50 0.00 As At End of Current Quarter As At Preceding Financial Year End 7 Net Assets Per Share (RM) 0.3200 0.3000 Remarks: You are advised to read the entire contents of the announcement or attachment. To read the entire contents of the announcement or attachment, please access the Bursa website at http://www.bursamalaysia.com
Even more careful when you see a hardcore salesperson pitching over and over ... beware... possible trying to get late entrance investors to push up for them
J&J just reported their extraordinary results. Dividends increase further. This shows the resilience of medical industry in time of pandemic. There's a strong indication of Scomnet's largest customer Edwards Lifesciences growth which will boost Scomnet another record breaking revenue.
think J&J is more involved in consumer healthcare products. However, i would say it should benefit indirectly from this pandemic, thanks to the fiscal spending that boost consumption..
This company should benefit further due to the lack of medical devices in every parts of the world, even in developed countries. As you can see from Donald Trump's tweet below.
--------------------------- From Donald Trump's tweet:
Donald J. Trump @realDonaldTrump Cuomo’s been calling daily, even hourly, begging for everything, most of which should have been the state’s responsibility, such as new hospitals, beds, ventilators, etc. I got it all done for him, and everyone else, and now he seems to want Independence! That won’t happen! ------------------------
Not only that, closer to home, the DG of health has now started asking for help due to the shortage of PPE.
At P/e 25x, it seems that the target price given by rakuten is way too defensive. Take a look at the stretched p/e of gloves counters.
the current p/e for its major customers as below : Edwards lifesciences iss 40.31 Ambu A/S : 174 (yes, 174!!) - gained > 80% year to date ( due to its single-use endoscopes that helps to prevent cross-contamination in hospitals).
So, it's not too much if this stock is able to trade at least p/e 30x or and above... which is about 1.10 on 20% eps growth (1st post in i3, you buy because for its prospects on future earnings)
-----------------------------------------
Health care remains something of a haven during periods of market turbulence. When the S&P 500 index lost 12% last month, the shares of health-care companies lost only 3.8% when the comparable measures for the financial and energy industries declined 21% and 35%, respectively. During the last recession, between December 2007 and June 2009, health care retreated 25% when the S&P 500 decreased 35%, according to data compiled by Bloomberg.
As usual, U can wait for the selling force to subside first before deciding to go in. - ( if u have followed my posts, this trade strategies so far works well 2 times). .#Believer wins
Be careful what rakuten call, they want ur business...they want ur trade..it won’t last as always...everyday they will pick one or two for u..mostly go south afterwards...do ur homework don’t follow them blindly. See their research and calls..u will know what I meant
I think this is a hidden gem health care stock. My friend stay near to this company in Sg Petani and his neighbour work in this company, he told me the business is very busy even with MCO in place bcos of overwhelming orders.
His neighbour work very hard mow, even sunday also go to work and this company has mco exemption approval.
It's quite amazing that people compares gloves manufacturer valuation with a totally different product business i.e. scomnet that is involved with PVC Compound and cables/wires for electronic devices and data control switches...
@t_nike so what your problem , ppl wanna promote this counter... and u keep attack ... tak beli sudahlah keep come scomnet here to kacau... why u wanna buy cheap cheap izit
Posted by t_nike2002 > Apr 15, 2020 11:55 AM | Report Abuse
It's quite amazing that people compares gloves manufacturer valuation with a totally different product business i.e. scomnet that is involved with PVC Compound and cables/wires for electronic devices and data control switches...
btw @gemstar thanks for telling everyone that u r hardcore promoter who ignores facts... Also this site is a free place for anyone to comment and not a communist place like what you want it to be...
@Gemstar. Unless you consider yourself hardcore promoter and taking the actions of a hardcore promoter, which is why you are responding to the posting.
I am posting for general public and i can post anywhere. Who ask you to read ? I cannot force you to read or buy/sell stock.
I am just posting FACTS here and smart investors will know what to do. Unlike some promoters just posting all unsubstantiated info.
@t nike then who ask u to read and reply my posting, Those ppl also post FACTS about this scomnet company that their earning and invest in medical supply ma... to u.s and Europe ..
Okay, please. No point arguing in an online forum. Nobody wins and it never ends. If there is anything good to discuss then discuss. If nothing good to say then just don't.
Good point @lancefire. It's just not worth to reply to hardcore promoter's comments which just copy someone else reply and blindly promote stock hoping some late investors can push up for them.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
yeoqian
33 posts
Posted by yeoqian > 2020-04-13 14:46 | Report Abuse
First barrier, around 71-73c.. If this area is valid, we should see further upside.
This is a growth stock during the virus pandemic, given that the healthcare p/e is 30x on average.. p/e of 20x seems way too cheap..
-------
mentioned in my previous post.. so hopefully this will continue.. believer wins..